論文・技術情報追加のお知らせ

①Cardiotoxicity with human epidermal growth factor receptor-2 inhibitors in breast cancer: Disproportionality analysis of the FDA adverse event reporting system.

HER-2阻害剤と心血管系毒性についての報告オッズ比評価

対象DB：FAERS

②Re: Singh et al.: Vaccine-associated uveitis following COVID-19 vaccination: vaccine adverse event reporting system database analysis. (Ophthalmology. 2023;130: S0161-6420(22)00672-8. doi: 10.1016/j.ophtha.2022.08.027. Published online ahead of print).

COVID-19ワクチン接種後のワクチン関連ぶどう膜炎についてのVAERSデータベース解析

対象DB：VAERS

③Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System.

FAERSを用いたベムラフェニブ関連の有害事象解析研究

対象DB：FAERS

④Time to Onset of Gemcitabine-induced Thrombotic Microangiopathy in a Japanese Population: A Case Series and Large-scale Pharmacovigilance Analysis.

JADERを用いたG-TMAの発症時間解析研究

対象DB：JADER

⑤Analysis of Prednisolone-Induced Osteoporosis Using the Japanese Adverse Drug Event Report Database.

JADERを用いたプレドニゾロン投与による骨粗鬆症についての評価

対象DB：JADER

⑥Adverse events related to antimuscarinics and beta-3-agonist: "real-life" data from the Eudra-Vigilance Database.

EudraVigilanceで報告された抗ムスカリン薬およびβ3-アゴニスト関する有害事象分析

対象DB：EudraVigilance